About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Rb1tm1.1Jyjw
targeted mutation 1.1, Jean YJ Wang
MGI:2445439
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Rb1tm1.1Jyjw/Rb1tm1.1Jyjw 129S6.129-Trp53tm1Tyj Rb1tm1.1Jyjw MGI:3769500
hm2
Rb1tm1.1Jyjw/Rb1tm1.1Jyjw either: (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) or (involves: 129S4/SvJae * 129S6/SvEvTac) MGI:2651660
ht3
Rb1tm1.1Jyjw/Rb1+ either: (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) or (involves: 129S4/SvJae * 129S6/SvEvTac) MGI:3769471
cx4
Rb1tm1.1Jyjw/Rb1tm1.1Jyjw
Trp53tm1Tyj/Trp53tm1Tyj
129S6.129-Trp53tm1Tyj Rb1tm1.1Jyjw MGI:3769498


Genotype
MGI:3769500
hm1
Allelic
Composition
Rb1tm1.1Jyjw/Rb1tm1.1Jyjw
Genetic
Background
129S6.129-Trp53tm1Tyj Rb1tm1.1Jyjw
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rb1tm1.1Jyjw mutation (0 available); any Rb1 mutation (111 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
N
• mice do not develop lymphomas over the same period that such tumors develop in Trp53-null mice




Genotype
MGI:2651660
hm2
Allelic
Composition
Rb1tm1.1Jyjw/Rb1tm1.1Jyjw
Genetic
Background
either: (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) or (involves: 129S4/SvJae * 129S6/SvEvTac)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rb1tm1.1Jyjw mutation (0 available); any Rb1 mutation (111 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 5 days after LPS injection, 50% of males recover compared to 33% of wild-type mice
• no mutant females recover (survive) compared to about 33% of wild-type mice or heterozygous females
• on the 129Sv background a 20% reduction in number of homozygous offspring is noted

behavior/neurological
• sign of endotoxemia, displayed when animals are treated with LPS
• sign of endotoxemia, displayed when animals are treated with LPS

vision/eye
• in cultured retina explants, apoptosis in the ganglial cell layer (GCL) resulting from severing of neuronal connections in the retina is reduced compared to wild-type explants

cellular
• in cultured retina explants, apoptosis in the ganglial cell layer (GCL) resulting from severing of neuronal connections in the retina is reduced compared to wild-type explants
• in response to LPS treatment, apoptosis in the intestine is significantly reduced compared to wild-type mice




Genotype
MGI:3769471
ht3
Allelic
Composition
Rb1tm1.1Jyjw/Rb1+
Genetic
Background
either: (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) or (involves: 129S4/SvJae * 129S6/SvEvTac)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rb1tm1.1Jyjw mutation (0 available); any Rb1 mutation (111 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 5 days after LPS injection, 58% of males recover compared to 33% of wild-type mice; mutant females show about 25% recovery, not significantly different from wild-type

behavior/neurological
• sign of endotoxemia, displayed when animals are treated with LPS
• sign of endotoxemia, displayed when animals are treated with LPS

vision/eye
• in cultured retina explants, apoptosis in the ganglial cell layer (GCL) is reduced compared to wild-type explants; this protection is transient and somewhat less compared to homozygous mutants

cellular
• in response to LPS treatment, apoptosis in the intestine is significantly reduced compared to wild-type mice
• in cultured retina explants, apoptosis in the ganglial cell layer (GCL) is reduced compared to wild-type explants; this protection is transient and somewhat less compared to homozygous mutants




Genotype
MGI:3769498
cx4
Allelic
Composition
Rb1tm1.1Jyjw/Rb1tm1.1Jyjw
Trp53tm1Tyj/Trp53tm1Tyj
Genetic
Background
129S6.129-Trp53tm1Tyj Rb1tm1.1Jyjw
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rb1tm1.1Jyjw mutation (0 available); any Rb1 mutation (111 available)
Trp53tm1Tyj mutation (12 available); any Trp53 mutation (240 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice become moribund from lymphoma involving various tissues within >30 weeks; mice with aggressive lymphoma have a mean survival time of 18 weeks

digestive/alimentary system
• after 7 days of DSS treatment, size of induced ulcers is significantly lower than in Trp53 single mutant littermates
• there is a significantly higher incidence of colon tumors in moribund mice with disseminated lymphoma than in Trp53-null single mutant littermates
• tumors have mixture of inflammatory infiltrates within the tumor areas and luminal surface have disrupted epithelial barrier, while colonic tumors
• aggressive adenocarcinoma of the colon is observed in double mutants whereas only 1 Trp53 single mutant developed that tumor type; tumors extend through the muscularis mucosa, submucosa, and muscularis, reaching the pericolonic fat

neoplasm
• there is a significantly higher incidence of colon tumors in moribund mice with disseminated lymphoma than in Trp53-null single mutant littermates
• tumors have mixture of inflammatory infiltrates within the tumor areas and luminal surface have disrupted epithelial barrier, while colonic tumors
• aggressive adenocarcinoma of the colon is observed in double mutants whereas only 1 Trp53 single mutant developed that tumor type; tumors extend through the muscularis mucosa, submucosa, and muscularis, reaching the pericolonic fat
• mice develop lymphomas, with ~same time of onset and same survival time as Trp53-single mutants
• median survival time of mice with teratomas is 7 weeks compared to 10 weeks for Rb1-sufficient, Trp53-null mice
• higher percentage of teratomas show necrosis with hemorrhage, and are more frequently associated with metastasis than teratomas in Trp53-null single mutant littermates
• ~30% of mice surviving beyond median survival age show extratesticular teratomas in lung, liver, lymph nodes, and/or pancreas
• incidence of testicular tumors is higher than in Trp53 single mutant littermates

cellular
• apoptosis of colonic epithelium is lower in double mutants than in Trp53-nulls after treatment with dextran sodium sulfate (DSS) to induce colonic injury

growth/size/body
• with DSS treatment, double mutants have a reduced average weight loss (loss of 9% body weight) compared to Trp53 single mutants (loss of 14% body weight)

endocrine/exocrine glands
• incidence of testicular tumors is higher than in Trp53 single mutant littermates

reproductive system
• incidence of testicular tumors is higher than in Trp53 single mutant littermates





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory